[ad_1] As there are currently no clinically validated vaccines and limited therapeutic treatments for SARS-CoV-2, the development of new therapies is a worldwide effort, with neutralizing antibodies as a central component. However, traditional antibody production suffers from long development times and costly production. As an alternative to human antibodies, nanobodies …
Read More »Synthetic nanobodies show potential for novel COVID-19 therapeutics
